Method of treatment of diabetes and/or obesity with reduced nausea side effect
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 18, 2011
Grant Date -
Sep 6, 2007
app pub date -
Nov 9, 2006
filing date -
Nov 9, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides methods of administering an insulinotropic peptide in an amount effective to treat a disorder or condition while reducing nausea side effect by administering to a subject in need thereof an insulinotropic peptide conjugated to albumin. The present invention also provides methods of selecting a subject for administration of a conjugated insulinotropic peptide. Exemplary disorders or conditions treatable with an insulinotropic peptide include obesity and type II diabetes.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully